Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
To avoid irritation: Use medical-grade formulations from reputable sources
Trastuzumab emtansine plus pertuzumab versus taxane plus trastuzumab plus pertuzumab after anthracycline for high-risk human epidermal growth factor receptor 2-positive early breast cancer: the phase III KAITLIN study
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin [PMID: 22962027] Laboratory literature summary: Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected
This product is made without any genetically modified organisms (GMOs)
US$ 21.71
US$ 29.47
US$ 24.68
US$ 22.23
US$ 21.85
US$ 24.01
US$ 20.52
US$ 28.90
US$ 28.90
US$ 26.61
US$ 24.06
US$ 28.13
